Plethico Pharmaceuticals Ltd vs Zydus Lifesciences Limited

A side-by-side comparison of Plethico Pharmaceuticals Ltd (PLETHICO) and Zydus Lifesciences Limited (ZYDUSLIFE) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, Zydus Lifesciences Limited leads PLETHICO vs ZYDUSLIFE on 11 of 14 metrics. See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

  • Valuation22
  • Profitability04
  • Growth02
  • Size & financial health13
ValueReturnsMarginGrowthScaleLow debt

Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.

Valuation

Even

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

0.00
P/E ratio
22.42
0.00
P/B ratio
4.11
0.00%
Dividend yield
0.09%
₹32.49
EPS
₹50.09

Profitability

ZYDUSLIFE takes 4/4

How efficiently each company turns capital and sales into profit. Higher is better.

7.43%
Return on equity
18.59%
10.00%
Return on capital
18.07%
14.00%
EBITDA margin
31.22%
5.39%
Net margin
18.87%

Growth

ZYDUSLIFE takes 2/2

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

10.45%
Revenue CAGR (3Y)
16.35%
-23.09%
Profit CAGR (3Y)
34.80%

Size & financial health

ZYDUSLIFE takes 3/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹0 Cr
Market cap
₹1.12L Cr
₹2,060 Cr
Revenue
₹27,148 Cr
₹111 Cr
Net profit
₹5,124 Cr
0.00
Debt / equity
0.46
Plethico Pharmaceuticals Ltd
  • + ["Company has reduced debt.", "Stock is trading at 0.02 times its book value"]
  • − ["Though the company is reporting repeated profits, it is not paying out dividend", "Company has low interest coverage ratio.", "Company has a low return on equity of 9.07% over last 3 years.", "Contingent liabilities of Rs.1,518 Cr.", "Company has high debtors of 198 days.", "Company's cost of borrowing seems high"]
Zydus Lifesciences Limited
  • + ["Company has delivered good profit growth of 18.6% CAGR over last 5 years", "Company has a good return on equity (ROE) track record: 3 Years ROE 20.9%"]
  • − []
Plethico Pharmaceuticals Ltd full analysis Zydus Lifesciences Limited full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.

PLETHICO vs ZYDUSLIFE: Share Price, Valuation & Which to Buy | DocStoX